Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide vs Sitagliptin Added to Metformin in Type 2 Diabetes
NCT00700817Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jun 2008
- Primary completion
- Jun 2009
- Modality
- Peptides
- Countries
- 15
01
Overview
A Phase 3 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Jun 2008; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00700817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00700817.